TherapeuticsMD Inc (TXMD) stock news · rev $3.0M
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
This TXMD news page leads with what TherapeuticsMD Inc filed — not a scraped headline mill.
No cached 8-K sentence for TXMD yet. We will not pad this page with generic market recap.
Latest reported TXMD revenue for 2025-12-31 was $3.0M. Net income was -$569.0K. Revenue was up 71.6% from 2024-12-31 to 2025-12-31. TXMD currently screens at market cap $13.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TXMD stock page; for the tape open the quote page.
TXMD stock news FAQ
What are TXMD's latest revenue and net income?
Latest cached TherapeuticsMD Inc (TXMD) revenue for Dec 31, 2025 was $3.0M. Net income was -$569.0K. Statements: https://lician.com/financials/txmd
How did TXMD revenue change from the prior cached period?
Cached TherapeuticsMD Inc (TXMD) revenue was up 71.6% from $1.8M (Dec 31, 2024) to $3.0M (Dec 31, 2025). Statements: https://lician.com/financials/txmd
What is TXMD's market cap?
TherapeuticsMD Inc (TXMD) market cap is $13.7M on the latest cached fundamentals snapshot.
What kind of company is TXMD?
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Where is TXMD stock news listed?
Cached stock news for TherapeuticsMD Inc (TXMD) is listed at https://lician.com/news/txmd. Filings: https://lician.com/sec/txmd
Not investment advice.